Concord Medical Services Holdings Limited (NYSE:CCM – Get Free Report) was the target of a significant increase in short interest in February. As of February 28th, there was short interest totalling 6,300 shares, an increase of 110.0% from the February 13th total of 3,000 shares. Currently, 0.3% of the shares of the stock are sold short. Based on an average daily volume of 8,800 shares, the short-interest ratio is presently 0.7 days.
Concord Medical Services Trading Up 4.1 %
NYSE CCM opened at $4.36 on Friday. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.46 and a current ratio of 0.47. Concord Medical Services has a 1-year low of $3.82 and a 1-year high of $26.70. The stock’s 50 day simple moving average is $4.80 and its 200-day simple moving average is $5.51.
Analyst Ratings Changes
Separately, StockNews.com began coverage on shares of Concord Medical Services in a research report on Sunday. They set a “sell” rating for the company.
Concord Medical Services Company Profile
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.
Featured Stories
- Five stocks we like better than Concord Medical Services
- What Are Dividend Contenders? Investing in Dividend Contenders
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Business Services Stocks Investing
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Canada Bond Market Holiday: How to Invest and Trade
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.